Article
A mutation hot spot in the Bcrp1 (Abcg2) multidrug transporter in mouse cell lines selected for Doxorubicin resistance.
Cancer research - 15 Apr 2002
Allen John D, Jackson Sonja C, Schinkel Alfred H
Abstract excerpt
The recent identification of mutations at arginine 482 (R482) in human Breast Cancer Resistance Protein (BCRP) in two drug-selected cell lines largely explains some discrepancies observed in the cross-resistance profiles of human cell lines overexpressing this multidrug transporter. We find that each of three mouse cell lines independently selected for resistance to the anthracycline doxorubicin also acquired...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
